Drug Injury Lawyer Blog

HughesNet Canadian Class Action? Xplornet, C-Com, and Galaxy Broadband

Tue, 18 Nov 2008 12:35:17 -0500

Following the HughesNet Class Action lawsuit filed by the law firm of Pogust, Braslow & Millrood, LLC, which in part asserts claims by subscribers for unlawful early termination fees (ETF) and fraudulent business practices involving slow-broadband service, lack of Internet accessibility and connectivity, there have now been a number of inquiries from Canadian residents with similar Complaints.

Overtime Pay for Interstate Drivers

Mon, 17 Nov 2008 17:46:44 -0500

The Fair Labor and Standards Act, which establishes rules for employers concerning maximum hours and overtime wages, has several clauses that excuse some employers from having to pay time and one-half for overtime wages. One such exemption provides that getting paid time and one-half for overtime hours is not required for any employee with respect to who the Secretary of Transportation has power to establish qualifications and maximum hours of service pursuant to the provisions of the Motor Carrier Act (“MCA”).

ADT Alerted to its Own Overtime Violations

Thu, 13 Nov 2008 19:27:04 -0500

On August 28, 2008, a group of current employees sued ADT Security Services, Inc. for failing to pay time and one-half for overtime hours worked, as required by the federal Fair Labor and Standards Act. The employees include those with positions as service and maintenance technicians as well as commercial and residential installers also known as installation technicians.

Forest Agrees to Settle Securities Class Action for $65 Million

Wed, 12 Nov 2008 11:09:57 -0500

On Monday, November 10, 2008, Forest Laboratories, Inc. filed a quarterly report with the Securities and Exchange Commission, revealing that it had agreed in principle to a settlement amounting to $65 million in In re: Forest Laboratories, Inc. Securities Litigation, 05-cv-02827 (S.D. NY).

U.S. Consumer Product Safety Commission Report Highlights Yamaha Rhino Related Injuries

Mon, 10 Nov 2008 11:35:21 -0500

Oct. 15, 2008, the U.S. Consumer Product Safety Commission released the 2007 Annual Report of All-Terrain Vehicle (ATV)-Related Deaths and Injuries, which compiled ATV-related fatality information available to CPSC staff as of Dec. 31, 2007, and ATV-related injury data for emergency-room-treated injuries occurring through Dec. 31, 2007.

FDA Mulls a Ban on Avandia

Fri, 07 Nov 2008 16:56:18 -0500

The FDA recently announced that it would consider whether to pull GlasxoSmithKline’s former top-selling drug, Avandia, off the market or allow it to stay on the market with stronger warnings after discovering evidence indicating that the drug may cause liver toxicity, resulting in liver failure and death.

HughesNet Early Termination Fees Revisited? The Sprint-Nextel Case

Thu, 06 Nov 2008 11:33:49 -0500

Preemption Update: Wyeth v. Levine

Wed, 05 Nov 2008 14:29:37 -0500

On Monday, November 3, 2008, the United States Supreme Court heard oral argument in Wyeth v. Levine, and we have the full draft transcript available for you here: Wyeth v. Levine (Oral Argument Transcript)

Preemption May Spell Tragedy for Women

Thu, 30 Oct 2008 13:21:26 -0500

A report released yesterday by the national consumer rights group Center for Justice and Democracy entitled “The Bitterest Pill – How Drugs Companies Fail to Protect Women and How Lawsuits Save Their Lives” revealed the devastating consequences that the regulatory failures and inadequacies of the FDA have had, specifically on women.

Brief Primer on Predatory Lending --- What Every Borrower Should Know

Wed, 29 Oct 2008 10:55:29 -0500

There are a number of key concepts and principals every borrower should know concerning the issue of predatory lending, including what it is, and what relief is available to those adversely affected by such illicit practice.

Decoy Indication: New Hybrid Method for Off Label Promotion of Medications?

Tue, 28 Oct 2008 14:13:40 -0500

A recent article published by the Public Library of Science Medicine (PLoS Medicine), has highlighted new innovative ways in which pharmaceutical companies are promoting medications for off-label use.

Consumers Fight-Back Against Slow Internet Service, Limited Bandwidth, and Egregious Customer Fees --- Comcast, HughesNet and Qwest

Wed, 22 Oct 2008 10:46:07 -0500

This past year has been a “bellwether” year for consumer advocacy groups with respect to reform and Internet Service Providers (“ISPs”).

Bard® Perfex® Hernia Plug --- Increased Risk of Nerve Entanglement?

Tue, 21 Oct 2008 09:00:20 -0500

The Bard® PerFix® Plug, introduced by Davol, Inc. and C.R. Bard, Inc., in 1993, is a medical device used to repair “primary and recurrent inguinal hernias.”

Pfizer Will Agree to Pay $894 Million to Settle Celebrex and Bextra Claims

Mon, 20 Oct 2008 09:00:38 -0500

Pfizer has recently announced that it will "resolve substantially all of the personal injury cases, consumer fraud cases and state attorneys general claims involving its non-steroidal anti-inflammatory (NSAID)" pain medications Bextra and Celebrex, which Pfizer voluntarily withdrew from the U.S. market in 2005.

Psoriasis Drug Raptiva Gets “Black Box” Warning - Associated Risk of Infection and PML

Sun, 19 Oct 2008 12:55:44 -0500

Just this week, the psoriasis drug Raptiva received a “black box” warning, the FDA’s strongest, regarding progressive multifocal leukoencephalopathy (PML) and other potentially fatal infections. Raptiva, manufactured by Genentech, is a medication given via weekly injection to treat moderate to severe plaque psoriasis in adults only. Raptiva is a biologic drug that works to suppress the immune system with the goal of fewer psoriasis flare-ups. However, as with any immunosuppressant, the use of Raptiva compromises the immune system to such an extent that it increases the risks of serious infections, some fatal, and other malignancies.